Groundbreaking Achievement: Study Of Ensartinib As Postoperative Adjuvant Therapy Published In The New England Journal Of Medicine

(MENAFN - PR Newswire) HANGZHOU, China, July 8, 2026 /PRNewswire/ -- On July 8, the study of Betta's ensartinib as postoperative adjuvant therapy for patients with stage IB–IIIB (T3N2M0) ...